Bernadette Marley’s Post

Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations.   Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement   These findings emphasize the critical role of technology in optimizing oncological response evaluation.   Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T   #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting

Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations.   Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement   These findings emphasize the critical role of technology in optimizing oncological response evaluation.   Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T   #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting

Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations.   Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement   These findings emphasize the critical role of technology in optimizing oncological response evaluation.   Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T   #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting

Delighted to share this study led by Dr. med. Inka Ristow, MHBA, Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations.   Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement   These findings emphasize the critical role of technology in optimizing oncological response evaluation.   Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T   #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting

Delighted to share this study led by Dr. med. Inka Ristow, MHBA, Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations.   Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement   These findings underscore the critical role of technology in optimizing oncological response evaluation.   Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T   #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting

Delighted to share this study led by Dr. med. Inka Ristow, MHBA, Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations.   Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement   These findings emphasize the critical role of technology in optimizing oncological response evaluation.   Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T   #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting

The future of personalised healthcare   This week our Head of Diagnostics, Diana Nielson, presented at the Pathology Technology Australia Congress 2024.   The panel, including Professor David Thomas, CEO of Omico and Krystal Barter, Founder and Owner of Humanise Health, discussed the evolving landscape of healthcare delivery and personalised healthcare models, including companion diagnostics, at-risk screening and early intervention; and explored the merits of moving towards a preventative, predictive and personalised healthcare model.   #NoPatientLeftBehind #WhatScienceCanDo 

Looking forward to #IMRP2024! We are committed to advancing innovation and sustainability in irradiation technologies. Be sure to visit our leaders on-site, ready to share how we’re driving the future of safe healthcare. Don’t miss the chance to connect with our experts from Sotera Health Company, Nordion, Sterigenics, and Nelson Labs. Let’s continue safeguarding global health together! #SafeguardingGlobalHealth #InnovationInHealthcare #IMRP2024"

📣 Brinc Portfolio News The CEO of Strados Labs, Nick Delmonico, has been featured in the April edition of Applied Clinical Trials Magazine, shedding light on the critical role of integrating subjective and objective measures in respiratory trials! 🔬 In the article, Nick discusses how leveraging technology can provide drug developers with invaluable insights and evidence, ultimately advancing the field of respiratory medicine. 🔍 Dive deeper to this topic and read the full feature here: bit.ly/4dkMZec #Brinc #BrincVC #BrincPortfolioNews #BrincHealthInnovation #HealthInnovation #Healthcare #RespiratoryTrials #Technology #VentureAccelerator #Innovation